Stryker to Acquire Inari Medical for $4.9 Billion
Slice of Healthcare Team
Jan 08, 2025
Key Highlights
- Stryker to acquire Inari Medical for $80/share in cash, totaling approximately $4.9 billion.
- Acquisition strengthens Stryker’s Neurovascular business with Inari’s VTE mechanical thrombectomy solutions.
- Inari specializes in non-thrombolytic solutions for venous thromboembolism (VTE), impacting 900,000 lives annually in the U.S.
- Transaction expected to close by Q1 2025, subject to customary regulatory approvals.
- Financial impacts to be detailed during Stryker’s Q4 2024 earnings call on January 28, 2025.
Source: Globe Newswire
Notable Quotes
“ The acquisition of Inari expands Stryker's portfolio to provide life-saving solutions to patients who suffer from peripheral vascular diseases. ”
Kevin Lobo, Chair and CEO at Stryker
“ With Stryker’s capabilities and global infrastructure, we will be even better positioned to accelerate the development of innovative new solutions and expand our footprint. ”
Drew Hykes, CEO at Inari Medical
